{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/a4c5de36-8260-4222-8e38-ff997dc73436/6308b7f25c22540012615ea6?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"The Companies and Markets show: Cineworld flops, Hunting tops, Blockbuster drugs & HL's secret deal","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61b9b44742e856e989985776/1661515088343-526c076456d3e8a1373afba59725a330.jpeg?height=200","description":"<p>In a bumper episode of the Companies and Markets show Dan Jones hosts first a discussion of online versus in-person retailers, leading into Cineworld's bankruptcy struggles. </p><p><br></p><p>Then oil services Hunting and Wood Group are in the spotlight (for different reasons), as is Anglo Pacific. </p><p><br></p><p>Jennifer Johnson then joins the pod for the first time to look through her piece on <a href=\"https://www.investorschronicle.co.uk/news/2022/08/25/pharma-s-bright-new-stars/\" rel=\"noopener noreferrer\" target=\"_blank\">Blockbuster drugs</a>; which pharma companies still have these billion-dollar assets in the pipeline?</p><p><br></p><p>And finally funds editor Dave Baxter joins the pod to discuss his scoop on Hargreaves Lansdown's secret offer to one customer who was seeking to up sticks.</p><p><br></p><p>Dan Jones hosts Mark Robinson, Julian Hofmann, Alex Newman, Jennifer Johnson and Dave Baxter.</p><p><br></p>","author_name":"Investors' Chronicle"}